GO
Loading...

Government Agencies

More

  • FDA approves ADHD drug for binge-eating disorder Friday, 30 Jan 2015 | 5:11 PM ET

    WASHINGTON— Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder. About 2 percent of U.S. adults, or about 5 million people, have binge eating disorder, according to the Department of Health and Human Services. The Food and Drug Administration originally approved...

  • WASHINGTON, Jan 30- Pomegranate juice maker POM Wonderful cannot advertise that its pomegranate drinks treat or prevent heart disease or other ailments unless it has proof, a U.S. appeals court said Friday, upholding an order by the Federal Trade Commission. The U.S. Court of Appeals for the D.C. Circuit largely upheld a 2010 order by the Federal Trade Commission,...

  • NEW YORK— Sun Pharmaceuticals will sell the rights to one generic drug as part of its purchase of competitor Ranbaxy Laboratories, U.S. antitrust regulators said Friday. The Federal Trade Commission said the companies will sell Ranbaxy's interests in generic minocycline, an antibiotic used to treat several types of infections. Torrent Pharmaceuticals, an...

  • SAN FRANCISCO, Jan 30- Sharp gains in the U.S. dollar that have spurred grumbling from some big U.S. companies about the impact on profits are actually a positive sign for U.S. job creation, a top Federal Reserve official said on Friday. "CEOs that have international operations complain about it," Dallas Fed President Richard Fisher told Reuters in an interview.

  • ATLANTIC CITY, N.J.— The battle for the future of the Trump Taj Mahal casino heated up Friday as the National Labor Relations Board urged a judge to restore workers' benefits and soon-to-be-owner Carl Icahn said the cuts are "an essential sacrifice that must be made" to keep the casino open. About 100 union members hand-delivered a letter to Icahn's Manhattan...

  • WASHINGTON, Jan 30- POM Wonderful cannot advertise that its pomegranate juice drinks treat or prevent heart disease or other ailments unless it has proof, a U.S. appeals court said on Friday in upholding an order by the Federal Trade Commission. The U.S. Court of Appeals for the D.C. Circuit largely upheld a 2010 order by the Federal Trade Commission which found...

  • Court upholds deceptive ad claims against POM Friday, 30 Jan 2015 | 11:13 AM ET

    In a 3-0 decision, the U.S. Court of Appeals for the District of Columbia Circuit upheld a conclusion reached earlier by the Federal Trade Commission that many of POM's ads made misleading or false claims. "We see no basis for setting aside the commission's conclusion that many of POM's ads made misleading or false claims about POM products," wrote appeals judge...

  • WASHINGTON— A Justice Department inspector general report is disputing allegations by former CBS News correspondent Sharyl Attkisson that the federal government secretly monitored her personal computer. Attkisson, who has said her personal computer and work laptops were remotely accessed due to her reporting on topics including the Fast and Furious...

  • U.S. labor costs up solidly in fourth quarter Friday, 30 Jan 2015 | 8:32 AM ET

    WASHINGTON, Jan 30- U.S. labor costs rose solidly in the fourth quarter, which could keep the Federal Reserve on track to raise interest rates this year. The Employment Cost Index, the broadest measure of labor costs, increased 0.6 percent after an unrevised 0.7 percent gain in the third quarter, the Labor Department said on Friday. Economists polled by Reuters had...

  • UPDATE 1-U.S. FDA approves Bristol-Myers, J&J HIV pills Thursday, 29 Jan 2015 | 6:35 PM ET

    Jan 29- The U.S. Food and Drug Administration on Thursday approved two fixed-dose HIV pills that combine protease inhibitors- one made by Bristol-Myers Squibb Co and the other by Johnson& Johnson- both with a boosting agent produced by Gilead Sciences Inc.. Bristol-Myers said its drug, Evotaz, is a once-daily pill containing Reyataz, also known as atazanavir, a...

  • U.S. FDA approves Bristol-Myers' HIV drug Thursday, 29 Jan 2015 | 5:44 PM ET

    Jan 29- The U.S. Food and Drug Administration has approved the sale of Evotaz, a once-daily combination pill to treat HIV made by Bristol-Myers Squibb Co, the company said on Thursday. The new drug combines Reyataz, also known as atazanavir, a Bristol-Myers' protease inhibitor, with cobicistat, a boosting agent produced by Gilead Sciences Inc..

  • WASHINGTON, Jan 29- The new Republican chairman of the U.S. Senate Banking Committee said on Thursday he was "very interested" in requiring a government audit of the Federal Reserve and its portfolio. Senator Richard Shelby, an Alabama Republican, said in an interview with Bloomberg TV that Congress should not function as an extra Fed governor, but it should have...

  • WASHINGTON, Jan 29- The U.S. Federal Communications Commission raised a record-breaking $44.9 billion in the auction of so-called AWS-3 airwaves that closed on Thursday, far surpassing the expectations of experts and industry analysts. Major bidders included wireless carriers Verizon Communications Inc, AT&T Inc and T-Mobile US Inc as well as satellite TV...

  • NEW YORK— Sunbeam is recalling about 34,000 Holmes- branded space heaters because they can spray hot oil and possibly cause household damage or injuries. The U.S. Consumer Product Safety Commission said Sunbeam received about 40 reports of hot oil spraying out and causing property damage. The heaters were sold at Target stores and small department stores...

  • Labor board again accuses UPMC of anti-union tactics Thursday, 29 Jan 2015 | 12:59 PM ET

    PITTSBURGH— The National Labor Relations Board has again accused the University of Pittsburgh Medical Center of engaging in anti-union tactics. The complaint was announced Thursday by the Service Employees International Union, which has been trying for years to unionize some 3,500 non-clinical employees. But Maryanne Williams, who works as a medical...

  • The regulator's decision, which comes in over two months ahead of its review date, represents a fourth indication for the drug, sold by Johnson& Johnson and Pharmacyclics Inc. Although WM occurs only in up to 1,500 patients in the United States each year, the approval highlights the strength of the Imbruvica franchise, Roth Capital Partner's Joseph Pantginis...

  • FDA expands use of Imbruvica to treat rare form of cancer Thursday, 29 Jan 2015 | 11:29 AM ET

    Jan 29- The U.S. Food and Drug Administration said it cleared an expanded use of Imbruvica to treat Waldenström's macroglobulinemia, a rare form of cancer that begins in the body's immune system. The approval represents a fourth indication for the drug, sold by Johnson& Johnson and Pharmacyclics Inc, since its initial approval in November 2013.

  • Fed could wait until September to lift rates -BlackRock Thursday, 29 Jan 2015 | 10:47 AM ET

    NEW YORK, Jan 29- The U.S. "Using words such as solid growth and strong employment gains would allow the Fed to continue down previously telegraphed mid-year lift-off, but recognizing the near-term softness in inflation, combined with referencing international conditions, provides the central bank with the ability to wait until September to begin the...

  • Census: 1 in 5 children on food stamps Thursday, 29 Jan 2015 | 10:14 AM ET

    Numbers released by the Census Bureau Wednesday as part of its annual look at children and families show that one in five children were on food stamp assistance in 2014. The survey was taken last spring. The number of people receiving food stamps— now called the Supplemental Nutrition Assistance Program, or SNAP— spiked through the recession and has stayed at a...

  • New Jersey dispensary workers file unfair labor charges Thursday, 29 Jan 2015 | 8:53 AM ET

    United Food and Commercial Workers Union Local 152 says a majority of the 11 employees at the Compassionate Care Foundation in Egg Harbor Township have filed unfair labor practice charges with the National Labor Relations Board. Brian String, the president of Local 152, told The Philadelphia Inquirer that the dispensary was using "tricks from the usual...